Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLondon Capital Group Holdings Regulatory News (LCG)

  • There is currently no data for LCG

Directorate Change

18 Jul 2013 07:00

RNS Number : 5798J
London Capital Group Holdings PLC
18 July 2013
 



London Capital Group Holdings plc

("LCG" or the "Company")

Directorate changes

The Company announces that Mark Slade has today resigned his position as CEO of the Company for personal reasons. His resignation will take effect immediately although he will remain as a strategic adviser to the Company for the remainder of the year to ensure a smooth transition period. He also continues to be a shareholder in the Company.

The Board is pleased to announce that Kevin Ashby, 55, has been appointed to replace Mark Slade as CEO with immediate effect.

Kevin recently joined LCG as Chief Commercial Officer and was previously Chairman & Chief Executive of Saxo Capital Markets and responsible for Saxo Bank's operations in Asia Pacific. He was formerly CEO of Patsystems, a UK listed financial software company; Chairman of Velsys, a trading systems supplier; and CEO of WISe, the insurance e-commerce network. He was formerly an IT Partner and CIO at KPMG. Kevin's appointment is subject to regulatory approval.

Kevin has extensive knowledge of the retail derivatives industry having held a number of senior roles both in the UK and internationally. 

The Board is also pleased to announce that it has further strengthened the Company's management team with the appointment of John Jones as Chief Operating Officer and Head of Risk Management. John was previously European COO and Head of Risk at Liquid Capital, a specialist derivative trading firm and prior to that he held senior trading roles at both Bear Stearns and Citigroup. John's expertise of trading, operations and risk management will be of great benefit to those areas of the firm.

Giles Vardey, Chairman of LCG, said: 'The Board is sorry that Mark has made this personal choice but we all respect the reason for his decision. All members of the board wish him well and we are pleased that we have been able to promote Kevin Ashby to CEO. Kevin has a great deal of experience in our sector and has been a CEO in the past. His strategic vision and skills will continue to drive the improvements we are already making in the business. Kevin will also lead a strengthened management team with a new COO in John Jones.

Save as disclosed below there are no additional disclosures to be made in accordance with paragraph (g) of Schedule 2 of the AIM Rules in relation to Kevin Ashby.

Kevin Ashby has held the following directorships in the past five years:

KD Advisory Limited*

London Capital Group Limited*

Velsys Limited

Syncova Solutions Limited

 

*current directorships

Kevin Ashby was a director of PatSystems plc between 11 December 2002 and 3 January 2006 which entered in to a scheme of arrangement in 2003 in order to effect a distribution of excess capital to shareholders and move the company's listing from the main market to AIM.

Kevin Ashby was a director of Velsys Pte (Australia) a subsidiary of Velsys Limited between 14 September 2010 and 4 July 2011 which was placed into administration in 2011. Velsys settled with administrators in late 2012.

 For further information, please contact: 

 www.londoncapitalgroup.com

 

London Capital Group Holdings plc

Giles Vardey

Chairman

020 7456 7000

 

Cenkos Securities plc

Nicholas Wells/Camilla Hume

020 7397 8900

Smithfield Consultants

John Kiely

020 7360 4900

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAGGURUMUPWPPM
Date   Source Headline
13th Feb 20184:35 pmRNSPrice Monitoring Extension
6th Feb 201810:59 amRNSResult of General Meeting
8th Jan 201810:02 amRNSFurther re proposed cancellation of trading on AIM
22nd Dec 201711:48 amRNSProposed cancellation of trading on AIM
14th Dec 20175:03 pmRNSReplacement: Admission to NEX Market
13th Dec 20177:00 amRNSAdmission to the NEX Exchange Growth Market
10th Nov 20174:40 pmRNSSecond Price Monitoring Extn
10th Nov 20174:35 pmRNSPrice Monitoring Extension
28th Sep 20177:00 amRNSHalf-year Report
30th Jun 201710:20 amRNSResult of AGM
29th Jun 20177:00 amRNSFinal Results
9th Jun 20171:58 pmRNSNotice of AGM
6th Jun 20174:40 pmRNSSecond Price Monitoring Extn
6th Jun 20174:35 pmRNSPrice Monitoring Extension
12th May 20174:40 pmRNSSecond Price Monitoring Extn
12th May 20174:35 pmRNSPrice Monitoring Extension
19th Apr 20174:35 pmRNSPrice Monitoring Extension
3rd Apr 20177:00 amRNSChange of Registered Office
3rd Mar 20174:40 pmRNSSecond Price Monitoring Extn
3rd Mar 20174:35 pmRNSPrice Monitoring Extension
2nd Feb 20174:40 pmRNSSecond Price Monitoring Extn
2nd Feb 20174:35 pmRNSPrice Monitoring Extension
1st Feb 20177:00 amRNSBoard changes
6th Dec 20164:45 pmRNSResponse to FCA Consultation Paper
30th Nov 20165:30 pmRNSTotal Voting Rights
22nd Nov 201612:20 pmRNSJoint Share Ownership Plan and issue of Warrants
17th Nov 20163:22 pmRNSSubscription and Issue of Equity
30th Sep 201612:14 pmRNSHalf-year Report
29th Jul 20166:00 pmRNSTotal Voting Rights
6th Jul 20163:40 pmRNSResult of GM, Subscription, Open Offer, and TVR
6th Jul 20167:00 amRNSStatement on current trading
30th Jun 20163:25 pmRNSResult of AGM, GM
23rd Jun 20165:30 pmRNSDirector Declaration
21st Jun 20167:00 amRNSCircular re. proposed Subscription and Open Offer
15th Jun 201610:54 amRNSNotice of GM
8th Jun 20167:00 amRNSNotice of AGM
27th May 201611:25 amRNSStmnt re Share Price Movement
11th May 20161:45 pmRNSHolding(s) in Company
10th May 20166:20 pmRNSHolding(s) in Company
29th Apr 20167:20 amRNSFinal Results
26th Apr 20167:00 amRNSNotice of Results
24th Mar 20164:29 pmRNSNotice of Results
27th Jan 20167:00 amRNSPre-Close Trading Update
26th Jan 201610:05 amRNSHolding(s) in Company
31st Dec 20157:00 amRNSChange of Adviser
16th Nov 20157:00 amRNSChange of Registered Office
6th Nov 201510:55 amRNSDirector/PDMR Shareholding
15th Oct 20158:58 amRNSHolding(s) in Company
30th Sep 20157:00 amRNSIssue of Equity
25th Sep 20159:41 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.